Accuronix Therapeutics Inc
Saint Louis, MO · Biotech · Private
ACXT-3102, a targeted therapeutic molecule combining a sigma-2 receptor ligand with ferroptosis-inducing dm-erastin for pancreatic cancer treatment
- Grants
- $4.5M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20192020202120222023
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase I · Advancement of ACXT-3102 for the Treatment of Pancreatic Adenocarcinoma (PDAC) | $220,278 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase I · Advancement of ACXT-3102 for the Treatment of Pancreatic Adenocarcinoma (PDAC) | $220,278 | |
| Federal grant· 1 of 2 same day | Department of Health and Human Services · Phase II · Preclinical Development of ACXT-3102 for the Treatment of Pancreatic Adenocarcinoma (PDAC) | $1,014,729 | |
| Federal grant· 2 of 2 same day | Department of Health and Human Services · Phase II · Preclinical Development of ACXT-3102 for the Treatment of Pancreatic Adenocarcinoma (PDAC) | $2,033,915 | |
| Federal grant | Department of Health and Human Services · Phase II · Preclinical Development of ACXT-3102 for the Treatment of Pancreatic Adenocarcinoma (PDAC) | $1,019,186 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2720 | SCINTILLATION NANOTECHNOLOGIES INC | — | — |
| 2721 | COMPUTCHEM LLC | — | — |
| 2722 | MIDWEST BIOPROCESSING CENTER LLC | — | — |
| 2723 | Accuronix Therapeutics Inc | — | — |
| 2724 | Alveus Pharma | — | — |
| 2725 | SEVEN BIOSCIENCES, INC. | — | — |
| 2726 | DOTQUANT LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.